NO20015227L - Fremgangsmate for a oke effektiviteten til anti-cancer midler - Google Patents

Fremgangsmate for a oke effektiviteten til anti-cancer midler

Info

Publication number
NO20015227L
NO20015227L NO20015227A NO20015227A NO20015227L NO 20015227 L NO20015227 L NO 20015227L NO 20015227 A NO20015227 A NO 20015227A NO 20015227 A NO20015227 A NO 20015227A NO 20015227 L NO20015227 L NO 20015227L
Authority
NO
Norway
Prior art keywords
effectiveness
increasing
cancer agents
cancer
agents
Prior art date
Application number
NO20015227A
Other languages
English (en)
Other versions
NO20015227D0 (no
Inventor
Steven M Piver
David Silver
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of NO20015227D0 publication Critical patent/NO20015227D0/no
Publication of NO20015227L publication Critical patent/NO20015227L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
NO20015227A 1999-04-27 2001-10-25 Fremgangsmate for a oke effektiviteten til anti-cancer midler NO20015227L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/300,124 US6171620B1 (en) 1999-04-27 1999-04-27 Method of enhancing the efficacy of anti-tumor agents
PCT/US2000/011000 WO2000064455A1 (en) 1999-04-27 2000-04-24 Method of enhancing the efficacy of anti-tumor agents

Publications (2)

Publication Number Publication Date
NO20015227D0 NO20015227D0 (no) 2001-10-25
NO20015227L true NO20015227L (no) 2001-12-27

Family

ID=23157813

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015227A NO20015227L (no) 1999-04-27 2001-10-25 Fremgangsmate for a oke effektiviteten til anti-cancer midler

Country Status (18)

Country Link
US (3) US6171620B1 (no)
EP (1) EP1212068A4 (no)
JP (1) JP2002542296A (no)
KR (1) KR100693796B1 (no)
CN (1) CN1188137C (no)
AU (1) AU781301B2 (no)
BG (1) BG64940B1 (no)
BR (1) BR0010082A (no)
CA (1) CA2368618C (no)
HU (1) HUP0200840A3 (no)
IL (1) IL146012A0 (no)
MX (1) MXPA01010899A (no)
NO (1) NO20015227L (no)
NZ (1) NZ514521A (no)
PL (1) PL350918A1 (no)
RU (1) RU2271829C2 (no)
WO (1) WO2000064455A1 (no)
ZA (1) ZA200108012B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003531179A (ja) 2000-04-26 2003-10-21 クイーンズ ユニバーシティ アット キングストン 悪性細胞表現型に対し一酸化窒素模倣体を使用する処方および方法
US7678391B2 (en) * 2000-04-26 2010-03-16 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US20050142217A1 (en) * 2000-04-26 2005-06-30 Adams Michael A. Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
CA2498319A1 (en) * 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
SI2368553T1 (sl) 2003-04-08 2015-05-29 Progenics Pharmaceuticals, Inc. Farmacevtske formulacije, vsebujoče metilnatrekson
DE10361813A1 (de) * 2003-12-30 2005-09-08 Bionethos Holding Gmbh Verfahren zur Regeneration von Gewebe
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
ES2714198T3 (es) * 2005-03-07 2019-05-27 Univ Chicago Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
EP2120998B1 (en) 2006-11-28 2013-08-07 HanAll Biopharma Co., Ltd. Modified erythropoietin polypeptides and uses thereof for treatment
MX2009010550A (es) 2007-03-29 2009-12-14 Progenics Pharm Inc Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
PT2139890E (pt) 2007-03-29 2014-09-03 Wyeth Llc Antagonistas do receptor opióide periférico e respectivas utilizações
EP3064503A1 (en) 2007-03-29 2016-09-07 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
CA2713568C (en) 2008-02-06 2016-09-20 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
WO2009117669A2 (en) 2008-03-21 2009-09-24 The University Of Chicago Treatment with opioid antagonists and mtor inhibitors
EP2310038A4 (en) * 2008-05-15 2012-03-14 Edison Pharmaceuticals Inc TREATMENT OF HEARING AND BALANCE DISORDERS WITH COMPOUNDS HAVING ERYTHROPOIETIN ACTIVITY
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
PL230756B1 (pl) * 2015-09-11 2018-12-31 Univ Medyczny W Bialymstoku Erytropoetyna oraz inhibitor kinazy Brutona w postaci 2- cyjan o-N-( 2,5-dibromofenylo)- 3-hydroksy-2- butenamidu do zastosowania jako lek oraz ich zastosowanie do wytwarzania leku do terapii nowotworu
WO2019083023A1 (ja) * 2017-10-26 2019-05-02 国立大学法人筑波大学 癌の治療に使用するための組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
JP2632014B2 (ja) * 1988-03-03 1997-07-16 中外製薬株式会社 骨髄機能障害性貧血治療剤
JPH1067678A (ja) * 1996-06-20 1998-03-10 Chugai Pharmaceut Co Ltd 肝疾患治療用医薬組成物
US20020052309A1 (en) * 1996-09-11 2002-05-02 Athanasius A. Anagnostou Method of treating endothelial injury

Also Published As

Publication number Publication date
US6620779B2 (en) 2003-09-16
BR0010082A (pt) 2002-01-15
KR20020000557A (ko) 2002-01-05
AU4486300A (en) 2000-11-10
ZA200108012B (en) 2003-03-26
US6426094B2 (en) 2002-07-30
NZ514521A (en) 2003-07-25
IL146012A0 (en) 2002-07-25
BG106057A (en) 2002-04-30
PL350918A1 (en) 2003-02-10
JP2002542296A (ja) 2002-12-10
HUP0200840A2 (hu) 2002-07-29
WO2000064455A1 (en) 2000-11-02
BG64940B1 (bg) 2006-10-31
CN1188137C (zh) 2005-02-09
US20020198153A1 (en) 2002-12-26
NO20015227D0 (no) 2001-10-25
CN1352561A (zh) 2002-06-05
EP1212068A4 (en) 2007-03-14
CA2368618A1 (en) 2000-11-02
KR100693796B1 (ko) 2007-03-12
AU781301B2 (en) 2005-05-12
US6171620B1 (en) 2001-01-09
MXPA01010899A (es) 2003-06-24
HUP0200840A3 (en) 2003-04-28
US20010000730A1 (en) 2001-05-03
EP1212068A1 (en) 2002-06-12
CA2368618C (en) 2011-03-01
RU2271829C2 (ru) 2006-03-20

Similar Documents

Publication Publication Date Title
NO20015227L (no) Fremgangsmate for a oke effektiviteten til anti-cancer midler
NO20016169L (no) Hydraulisk setteverktöy
PT1181017E (pt) Inibidores de metaloproteases
SE9902595D0 (sv) Verktyg
DE60032892D1 (de) Schnellösemutter
DE60007050D1 (de) IMC-Verfahren
PT1194404E (pt) Inibidores de aspartil-protease
DE60016267D1 (de) Nietvorrichtung
ATE218675T1 (de) Befestigungsmittel
DE60110919D1 (de) Modulare antiseismische vorrichtung zum schutz von gebäuden
DE60029393D1 (de) Bolzen
DE50010446D1 (de) Emulsionen
DE60027109D1 (de) Vorrichtung zum Eliminieren von Blasen
DE60014790D1 (de) Vorrichtung zum Reduzieren von Rauschen
DE69909846D1 (de) Faltschachtel
ATE244992T1 (de) Sprühvorrichtung
DE60002824D1 (de) System zum Entwerfen von Primern
DE50003324D1 (de) Pulverkraftbetriebenes Setzgerät
DE50003014D1 (de) N-substituierte perhydrodiazine
DE69921620D1 (de) Vorrichtung zum Schweissen
FI3964U1 (fi) Pylväs
ITRM990062U1 (it) Progetto x
FI4251U1 (fi) Lokasuoja
SE9904160D0 (sv) Hjälpverktyg
UA34048A (uk) Горілка "ізумруд"

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application